These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3791555)

  • 1. Schedule-dependent antitumor and toxic effects of thymidine and 5-fluorouracil in AKR and L1210 leukemias.
    Santelli G; Valeriote F
    Cancer Chemother Pharmacol; 1986; 18(2):101-4. PubMed ID: 3791555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of molar ratio on the combination effect of 5-fluorouracil with guanosine 5'-monophosphate on P388 and L1210 leukemias.
    Iigo M; Hoshi A
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):411-5. PubMed ID: 6323189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schedule-dependent cytotoxicity of 5-fluorouracil in mice.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1986 Jan; 76(1):159-64. PubMed ID: 3455738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P; Cerna I
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting cytotoxicity kinetics of 5-azacytidine and dihydro-5-azacytidine hydrochloride in L1210 leukemia in mice.
    Presant CA; Coulter D; Valeriote F; Vietti TJ
    J Natl Cancer Inst; 1981 Jun; 66(6):1151-4. PubMed ID: 6165854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral injection of thymidine: enhancement of the antitumor activity and incorporation of 5-fluorouracil into tumor RNA in a murine tumor system.
    Matsuoka H; Masuda H; Maehara Y; Sugimachi K; Inokuchi K
    Cancer Treat Rep; 1986 Jul; 70(7):851-7. PubMed ID: 3719577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of both leukemic and normal cell population reduction following 5-azacytidine.
    Presant CA; Vietti T; Valeriote F
    Cancer Res; 1975 Aug; 35(8):1926-30. PubMed ID: 50128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pharmacokinetics of 5-fluorouracil and 5-fluorouracil with concurrent thymidine infusions in a Phase I trial.
    Kirkwood JM; Ensminger W; Rosowsky A; Papathanasopoulos N; Frei E
    Cancer Res; 1980 Jan; 40(1):107-13. PubMed ID: 7349890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of nitrogen mustard cytotoxicity to leukemia cells by sulfur-containing compounds administered in vivo.
    Valeriote F; Grates HE
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1165-9. PubMed ID: 3744935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacological studies of concurrent infusion of 5-fluorouracil and thymidine in treatment of colorectal carcinomas.
    Au JL; Rustum YM; Ledesma EJ; Mittelman A; Creaven PJ
    Cancer Res; 1982 Jul; 42(7):2930-7. PubMed ID: 6211226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo potentiation of 5-fluorouracil cytotoxicity against AKR leukemia by purines, pyrimidines, and their nucleosides and deoxynucleosides.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1980 Jan; 64(1):69-72. PubMed ID: 6928048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B potentiation of the cytotoxicity of anticancer agents against both normal hematopoietic and leukemia cells in mice.
    Valeriote F; Medoff G; Tolen S; Dieckman J
    J Natl Cancer Inst; 1984 Aug; 73(2):475-82. PubMed ID: 6589439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of concurrent calcium leucovorin infusion on 5-fluorouracil cytotoxicity against murine L1210 leukemia.
    Klubes P; Cerna I; Meldon MA
    Cancer Chemother Pharmacol; 1981; 6(2):121-5. PubMed ID: 6975667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
    Phelan ET; Vietti TJ; Valeriote FA; Coulter D
    Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.
    Wampler GL; Carter WH; Campbell ED
    Cancer Invest; 1987; 5(6):523-33. PubMed ID: 3442730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of nitrogen mustard cytotoxicity by disulfiram, diethyldithiocarbamic acid, and diethylamine in mice.
    Valeriote F; Grates HE
    Cancer Res; 1989 Dec; 49(23):6658-61. PubMed ID: 2555050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of L-histidinol to improve the therapeutic efficiency of 5-fluorouracil against murine breast tumors.
    Stolfi RL; Sawyer RC; Martin DS
    Cancer Res; 1987 Jan; 47(1):16-20. PubMed ID: 3791203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of drug sequence in therapeutic selectivity of the combination of 5-fluorouracil and cis-platin.
    Palmeri S; Trave F; Russello O; Rustum YM
    Sel Cancer Ther; 1989; 5(4):169-77. PubMed ID: 2623382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schedule-dependent antitumor activity and toxicity of combinations of 5-fluorouracil and cisplatin/carboplatin against L1210 leukemia-bearing mice.
    Fujimoto S
    Biol Pharm Bull; 2006 Nov; 29(11):2260-6. PubMed ID: 17077525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.